The notoginsenosides found in DKP are potential active ingredients for the treatment of obesity by reducing lipid synthesis, inhibiting adipogenesis, increasing energy expenditure, and improving insulin sensitivity [76]. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.